Based on the clinical trial data and the known mechanism, AOD 9604 does not appear to cause muscle loss
Clinically significant vitamin B 12 deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition, the person's dietary intake is below recommended levels
Recovering from illness or surgery , or if you get sick often
A smaller quantity may lead to frequent reorders, while a larger quantity may not be suitable if the plan is still being adjusted
The blood-vessel signaling associated with GHK-Cu, BPC-157, and TB-4 creates a theoretical concern, not a measured human tumor risk
This is likely due to its inhibitory effect on glutamate, a chemical found in the body